Bayer CEO on Lower Earnings, Monsanto Purchase, Roundup

The transcript discusses the market reaction to the Monsanto acquisition, highlighting growth in earnings and strategic benefits. It addresses concerns about the Roundup verdict, emphasizing the safety of glyphosate and the company's commitment to defending its product. The speaker expresses confidence in the acquisition's long-term benefits and outlines plans to appeal the legal verdict.

What was the primary reason for the lower earnings per share mentioned by the speaker?

• Increased operational costs

• Delayed closing of the Monsanto acquisition

• Decline in product sales

• Higher tax rates

How does the speaker describe the combination of the two companies after the Monsanto acquisition?

• A highly complementary and strong management team

• A strategic mistake

• A risky venture

• An uncertain future

What is the speaker's stance on the safety of glyphosate?

• It is only safe in small quantities

• It is controversial and needs more research

• It is safe and supported by scientific evidence

• It is unsafe and should be banned

What action does the speaker mention taking in response to the jury's verdict?

• Accepting the verdict

• Filing motions to overturn the verdict

• Settling the case out of court

• Discontinuing the product

What evidence does the speaker cite to support the safety of glyphosate?

• A single study conducted by the company

• Testimonials from farmers

• A recent survey of consumers

• Over 800 studies and a U.S. government-funded study

What is the speaker's response to the financial implications of the jury's decision?

• The company will halt all sales

• The company will pay the settlement

• The company will increase product prices

• The company will vigorously defend itself

How does the speaker express their feelings towards Mr. Johnson and his family?

• Indifference

• Confusion

• Hostility

• Sympathy